Credit Agricole
MYGN icon

Credit Agricole’s Myriad Genetics MYGN Stock Holding History

Credit Agricole’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-44,726
Closed -$1.53M – 373
2017
Q4 		$1.53M Sell
44,726
-99,686
-69% -$3.36M 0.1% 176
2017
Q3 		$5.22M Sell
144,412
-170,250
-54% -$4.86M 0.02% 645
2017
Q2 		$8.13M Buy
314,662
+293,763
+1,406% +$6.24M 0.03% 560
2017
Q1 		$401K Hold
20,899
– – ﹤0.01% 1420
2016
Q4 		$348K Buy
20,899
+869
+4% +$15.7K ﹤0.01% 1269
2016
Q3 		$412K Buy
20,030
+930
+5% +$23.6K ﹤0.01% 1353
2016
Q2 		$584K Buy
+19,100
New +$664K ﹤0.01% 1139

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Agricole's MYGN Position: Q1 2018 in Review

Credit Agricole sold out of Myriad Genetics (MYGN) in Q1 2018, closing a stake of 44,726 shares — an estimated $1.53M sold.

Credit Agricole first reported a position in MYGN in Q2 2016 and held it in 7 quarters. The position peaked at $8.13M in Q2 2017. 260 funds tracked by Wall St. Rank hold MYGN as of Q1 2018.

  • Credit Agricole reported no remaining Myriad Genetics position as of Q1 2018 after selling out during the quarter.
  • Credit Agricole sold 44,726 Myriad Genetics shares in Q1 2018, an estimated $1.53M.
  • Credit Agricole first reported a position in Myriad Genetics in Q2 2016 and held it in 7 quarters.
  • Credit Agricole's Myriad Genetics position peaked at $8.13M in Q2 2017.
  • 260 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2018.

Based on Credit Agricole's 13F filing for Q1 2018, filed 14 May 2018.